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Abstract. Auricular perichondritis is an uncommon com- 
plication following surgery of the external ear. Pseudo- 
monas aeruginosa is the most commonly associated path- 
ogen. Presented is a patient with auricular perichondritis 
successfully treated with norfloxacin, a newly available, 
orally administered antibiotic with antipseudomonal ac- 
tivity. 
INTRODUCTION 
Perichondritis of the external ear represents an un- 
common but potentially serious consequence of au- 
ricular trauma and/or surgery. The most common 
bacterial pathogen associated with auricular peri- 
chondritis is Pseudomonas aeruginosa.'r2 In more 
severe cases, hospitalization is required for inten- 
sive local care (debridement, drains for infusion of 
local antibiotics), as well as intravenous antibiotics 
with antipseudomonal activity. Before the intro- 
duction of 4-quinolone antibiotics, there had not 
been an oral antibiotic with good antipseudomonal 
activity. Norfloxacin, a recently available 4-quino- 
lone, is reported to have excellent antipseudomonal 
activity after oral admini~tration.~ Reported here is 
a patient who, following Mohs surgery, had auri- 
cular perichondritis successfully treated as an out- 
patient with norfloxacin. 
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CASE REPORT 
CASE REPORT 
A 64-year-old white man presented to the Cuta- 
neous Surgery and Oncology Unit, Department of 
Dermatology, at the University of Michigan with a 
history of recurrent basal cell carcinoma involving 
the concha of the right auricle. The tumor had been 
initially treated by electrodesiccation and curettage 
in 1957. In 1959, the tumor was treated by excision 
and a third recurrence was treated in 1970 by x-ray 
therapy. In 1984, Mohs micrographic surgery was 
employed to treat the fourth recurrence. Unfortu- 
nately the basal cell carcinoma again recurred, lead- 
ing to Mohs micrographic surgery on March 30, 
1987. 
The clinical exam revealed an ill-defined nodule 
overlying the right concha and measuring 1.5 x 
1.3 cm. No palpable lymph nodes were detected 
and there were no other significant physical find- 
ings. 
Because of the location and recurrent nature of 
the tumor, Mohs surgery, fresh tissue technique, 
was employed. A tumor-free plane was found after 
two stages with a final defect size of 2.1 x 1.9 cm 
(Fig. 1). Perichondrium was intact and we decided 
to allow the wound to heal by second intention. 
Careful patient instructions regarding proper 
wound care were given. 
The patient returned in seven days with com- 
plaints of ear pain, tenderness, and swelling, but 
no complaint of fever or chills. On exam, the entire 
right auricle was noted to be edematous, erythem- 
atous, and tender to touch. A yellow discharge was 
seen in association with the surgical defect. 
A culture of the wound was obtained followed 
by local debridement and cleaning. The patient was 
instructed to continue local wound care with dilute 
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acetic acid soaks t.i.d. followed by Bacitracin oint- 
ment and bandage. He was also started on cephal- 
exin 250 mg P.O. q.i.d. 
The patient returned in three days with no dis- 
cernible improvement in his clinical condition (Fig. 
2). He was afebrile but the ear remained swollen, 
erythematous, and tender. The culture from his 
wound grew Pseudomonas aeruginosa which was 
resistant to cephalexin (Table 1). The organism was 
sensitive to ticarcillin and gentamycin, which are 
both administered intravenously. The organism 
was found also to be sensitive to a new 4-quinolone 
antibiotic, norfloxacin, recently released for oral 
administration. 
TABLE 1 
Wound Culture Right Ear 
Culture Result-Numerous Pseudomonas Aeruginosa 

























































FIGURE 1. Post Mohs defect for recurrent basal cell car- 
cinoma of the right external ear. 
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FIGURE 2. Inflammation, edema, and purulent exudate 
at the site of surgery 7 days postoperatively. 
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FIGURE 3. Marked improvement after 2 weeks of nor- 
floxacin 400 mg P.O. b.i.d. 
FIGURE 4. Wound 2 weeks following norfloxacin 
therapy. 
Cephalexin was discontinued on day 3 and the 
patient began norfloxacin 400 mg P.O. b.i.d. The 
patient experienced marked subjective improve- 
ment within 48 hours. On his follow-up exam 7 
days after initiation of norfloxacin, the erythema, 
swelling, and tenderness were negligible (Fig. 3 ) .  
The norfloxacin was given for a total of 21 days and 
the patient experienced a subsequently uneventful 
convalescence (Fig. 4). 
DISCUSSION 
While perichondritis of the auricle is an uncommon 
complication following surgical procedures, it can 
be difficult to manage. Meticulous wound care and 
broad spectrum antibiotics have been the mainstays 
of therapy for less severe cases, whereas advanced 
cases have required hospitalization for more inten- 
sive care, including systemically administered an- 
tibiotics. Because of the high frequency of Pseu- 
domonas isolates in auricular perichondritis, it is 
surprising that more cases have not required intra- 
venous antibiotics. The introduction of the 4-quin- 
olone class of antibiotics marks the first antibiotics 
available per oral route for use in the treatment of 
systemic Pseudomonal infections. 
Norfloxacin was the first 4-quinolone antibiotic 
available in the United States. Norfloxacin and 
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other agents in this class were initially evaluated 
for use in urinary tract infections. It was found that 
this new class of antibiotics exhibits broad activity 
against many gram positive and gram negative bac- 
teria, including Pseudomonas species and Staphy- 
lococcus a ~ r e u s . ~ , ~  Norfloxacin is available only as 
an oral preparation and is generally well tolerated. 
Side effects have been uncommon (2-4%), the most 
common complaints being nausea, headache, and 
light-headedness. 
While norfloxacin to our knowledge has not been 
reported for the treatment of auricular perichon- 
dritis, its spectrum of activity, low incidence of ad- 
verse reactions, and oral administration prompted 
its use in our patient. The excellent response ob- 
tained in this patient merits further investigation of 
this drug in the treatment of auricular perichondri- 
tis. 
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Prognosis for Recurrent Stage I Malignant Mela- 
noma. DS Reintgen, R Vollmer, CY Tso, HF 
Siegler. Arch Surg 122:1338-1342, 1987. 
This retrospective study analyzed 1,504 (35.9%) pa- 
tients out of 4,285 who had metastases after treat- 
ment of their initial malignant melanoma. Initial re- 
currence site was local (skin, in-transit, or regional 
lymph nodes) and made up 62.5% of head and neck 
primaries, 77.3% of trunkal tumors, and 85.6% of 
extremity melanomas. One third of the head and 
neck melanomas had their initial recurrence sys- 
temically. There was an increased risk of initial re- 
currence even after a 5-year latency period. Sur- 
vival figures dropped from 88 to 42% in this group. 
Survival by site of recurrence was greatest for local 
disease > lymph node disease > systemic involve- 
ment. Statistical analysis of factors contributing to 
a worse prognosis after a recurrence were thickness 
of lesions, ulceration, a short disease-free interval, 
wide-local excision only, a primary extremity tu- 
mor, and older age of the patient. 
R. STEVEN PADILLA, M.D. 
Refinements in Combined Chemical Peel and Si- 
multaneous Abrasion of the Face. CE Horton, RC 
Sadove. Ann Plast Surg 19:504-509, 1987. 
The authors describe their technique of the use of 
a Baker's phenol formula chemical peel and im- 
mediate dermabrasion of the same facial area via a 
wire brush, which they have performed in over 500 
cases since 1973. They feel the combined approach 
retains the advantages of both procedures while 
eliminating some of their disadvantages. Eyelids 
are treated with peeling alone. One patient devel- 
oped a hypertrophic scar which resolved with con- 
servative management. 
HUBERT T. GREENWAY, JR. ,  M.D. 
Zoster-like leiomyomata. PA Guerra, M Poli- 
meni, G Santoro, SP Cannavo, Derm Clin 7:52-56, 
1987 (Italian). 
The authors report a case of a 35-year-old man with 
zoster-like multiple cutaneous leiomyomata of pilar 
origin; the patient had many papulonodular ele- 
ments that were aching spontaneously. He had re- 
current and severe neuralgic attacks of pain pro- 
voked by physical stimulation, emotion, and 
change of temperature. 
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